The Food and Drug Administration on Monday laid out a new pathway aimed at spurring novel individualized treatments targeting ...
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to ...
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy ...
The Trump administration announced a new FDA approval pathway for individualized gene editing for rare diseases.
The U.S. Food and Drug Administration issued two Emergency Use Authorizations for treating New World screwworm infestations ...
Months into his second term, President Donald Trump’s top health officials were clear. They promised to focus on “cures” and “meaningful treatments.” They wanted revolutionary medicine to be developed ...